{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:11:40Z","timestamp":1793643100908,"version":"4.5.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prog Biomater"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40204-022-00198-3","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:06:27Z","timestamp":1659078387000},"page":"321-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Therapeutic applications of curcumin nanomedicine formulations in cystic fibrosis"],"prefix":"10.1007","volume":"11","author":[{"given":"Cristina","family":"Quispe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Herrera-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbukhat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeeshan","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Semwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Painuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senem","family":"Kamiloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Martorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Calina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-8151","authenticated-orcid":false,"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"198_CR1","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2147\/IJN.S306831","volume":"16","author":"IM Adel","year":"2021","unstructured":"Adel IM, Elmeligy MF, Abdelrahim MEA, Maged A, Abdelkhalek AA, Abdelmoteleb AMM, Elkasabgy NA (2021) Design and characterization of spray-dried proliposomes for the pulmonary delivery of curcumin. Int J Nanomed 16:2667\u20132687","journal-title":"Int J Nanomed"},{"key":"198_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-030-56153-6_2","volume":"1291","author":"M Akaberi","year":"2021","unstructured":"Akaberi M, Sahebkar A, Emami SA (2021) Turmeric and curcumin: from traditional to modern medicine. Adv Exp Med Biol 1291:15\u201339","journal-title":"Adv Exp Med Biol"},{"key":"198_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.31925\/farmacia.2020.5.8","volume":"68","author":"ID Alexa","year":"2020","unstructured":"Alexa ID, Ilie AC, Prada G, Herghelegiu AM, Luca A, Rotaru TS, Dondas A, Rusu-zota G, Alexa-stratulat T, Bohotin CR (2020) A comprehensive behavioural assessment of curcumin\u2019s effect on inflammatory and non-inflammatory pain in mice. Farmacia 68:829\u2013834","journal-title":"Farmacia"},{"key":"198_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.109810","volume":"104","author":"M Ayubi","year":"2019","unstructured":"Ayubi M, Karimi M, Abdpour S, Rostamizadeh K, Parsa M, Zamani M, Saedi A (2019) Magnetic nanoparticles decorated with PEGylated curcumin as dual targeted drug delivery: synthesis, toxicity and biocompatibility study. Mater Sci Eng: C 104:109810","journal-title":"Mater Sci Eng: C"},{"issue":"1","key":"198_CR5","first-page":"2000509","volume":"57","author":"CD Bengtson","year":"2021","unstructured":"Bengtson CD, Kim MD, Anabtawi A, He J, Dennis JS, Miller S, Yoshida M, Baumlin N, Salathe M (2021) Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearance. Eur Respir J 57(1):2000509","journal-title":"Eur Respir J"},{"key":"198_CR6","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1074\/jbc.M412972200","volume":"280","author":"AL Berger","year":"2005","unstructured":"Berger AL, Randak CO, Ostedgaard LS, Karp PH, Vermeer DW, Welsh MJ (2005) Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity. J Biol Chem 280:5221\u20135226","journal-title":"J Biol Chem"},{"key":"198_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1021\/mp900138a","volume":"7","author":"MS Cartiera","year":"2010","unstructured":"Cartiera MS, Ferreira EC, Caputo C, Egan ME, Caplan MJ, Saltzman WM (2010) Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol Pharm 7:86\u201393","journal-title":"Mol Pharm"},{"key":"198_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1248\/bpb.b18-00928","volume":"42","author":"N Chaudhary","year":"2019","unstructured":"Chaudhary N, Ueno-shuto K, Ono T, Ohira Y, Watanabe K, Nasu A, Fujikawa H, Nakashima R, Takahashi N, Suico MA, Kai H, Shuto T (2019) Curcumin down-regulates toll-like receptor-2 gene expression and function in human cystic fibrosis bronchial epithelial cells. Biol Pharm Bull 42:489\u2013495","journal-title":"Biol Pharm Bull"},{"key":"198_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1089\/wound.2018.0927","volume":"8","author":"WT Chiu","year":"2019","unstructured":"Chiu WT, Tran TV, Pan SC, Huang HK, Chen YC, Wong TW (2019) Cystic fibrosis transmembrane conductance regulator: a possible new target for photodynamic therapy enhances wound healing. Adv Wound Care (new Rochelle) 8:476\u2013486","journal-title":"Adv Wound Care (new Rochelle)"},{"key":"198_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.msec.2018.10.064","volume":"95","author":"C Cristallini","year":"2019","unstructured":"Cristallini C, Barbani N, Ventrelli L, Summa C, Filippi S, Capeloa T, Vitale E, Albera C, Messore B, Giachino C (2019) Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier. Mater Sci Eng C Mater Biol Appl 95:19\u201328","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"198_CR11","unstructured":"Cystic Fibrosis Foundation (2020) About Cystic Fibrosis. Retrieved from: https:\/\/www.cff.org"},{"key":"198_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms21041233","volume":"21","author":"AO Docea","year":"2020","unstructured":"Docea AO, Calina D, Buga AM, Zlatian O, Paoliello MMB, Mogosanu GD, Streba CT, Popescu EL, Stoica AE, Birca AC, Vasile BS, Grumezescu AM, Mogoanta L (2020) The effect of silver nanoparticles on antioxidant\/pro-oxidant balance in a murine model. Int J Mol Sci 21:17","journal-title":"Int J Mol Sci"},{"key":"198_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.bbrc.2004.07.146","volume":"322","author":"A Dragomir","year":"2004","unstructured":"Dragomir A, Bjorstad J, Hjelte L, Roomans GM (2004) Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 322:447\u2013451","journal-title":"Biochem Biophys Res Commun"},{"key":"198_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1093941","volume":"304","author":"ME Egan","year":"2004","unstructured":"Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304:600\u2013602","journal-title":"Science"},{"key":"198_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1021\/mp200351y","volume":"9","author":"IM El-Sherbiny","year":"2012","unstructured":"El-Sherbiny IM, Smyth HD (2012) Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles. Mol Pharm 9:269\u2013280","journal-title":"Mol Pharm"},{"key":"198_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013007236","volume":"30","author":"G Flora","year":"2013","unstructured":"Flora G, Gupta D, Tiwari A (2013) Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst 30:331\u2013368","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"198_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejpb.2017.04.015","volume":"117","author":"C Goncalves","year":"2017","unstructured":"Goncalves C, Gomez JP, Meme W, Rasolonjatovo B, Gosset D, Nedellec S, Hulin P, Huin C, Le Gall T, Montier T, Lehn P, Pichon C, Guegan P, Cheradame H, Midoux P (2017) Curcumin\/poly(2-methyl-2-oxazoline-b-tetrahydrofuran-b-2-methyl-2-oxazoline) formulation: An improved penetration and biological effect of curcumin in F508del-CFTR cell lines. Eur J Pharm Biopharm 117:168\u2013181","journal-title":"Eur J Pharm Biopharm"},{"key":"198_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijpharm.2017.03.057","volume":"524","author":"MJ Guichard","year":"2017","unstructured":"Guichard MJ, Patil HP, Koussoroplis SJ, Wattiez R, Leal T, Vanbever R (2017) Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy. Int J Pharm 524:159\u2013167","journal-title":"Int J Pharm"},{"key":"198_CR19","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1042\/CS20180315","volume":"132","author":"MJ Guichard","year":"2018","unstructured":"Guichard MJ, Kinoo D, Aubriot AS, Bauwens N, Gougue J, Vermeulen F, Lebecque P, Leal T, Vanbever R (2018) Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum. Clin Sci (lond) 132:1439\u20131452","journal-title":"Clin Sci (lond)"},{"key":"198_CR20","doi-asserted-by":"publisher","first-page":"2000146","DOI":"10.1002\/adtp.202000146","volume":"4","author":"MJ Guichard","year":"2021","unstructured":"Guichard MJ, Wilms T, Mahri S, Patil HP, Hoton D, Ucakar B, Vanvarenberg K, Cheou P, Beka M, Marbaix E (2021) PEGylation of recombinant human deoxyribonuclease I provides a long-acting version of the mucolytic for patients with cystic fibrosis. Adv Ther 4:2000146","journal-title":"Adv Ther"},{"key":"198_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.31925\/farmacia.2020.2.16","volume":"68","author":"YH Guo","year":"2020","unstructured":"Guo YH, An BZ, Lang ZF, Zhou FB, Zhang XH, Wang HL (2020) Effects of curcumin on inhibiting the proliferation of pulmonary artery smooth muscle cells and relieving pulmonary arterial hypertension. Farmacia 68:307\u2013312","journal-title":"Farmacia"},{"key":"198_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbrc.2006.12.036","volume":"353","author":"K Harada","year":"2007","unstructured":"Harada K, Okiyoneda T, Hashimoto Y, Oyokawa K, Nakamura K, Suico MA, Shuto T, Kai H (2007) Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin. Biochem Biophys Res Commun 353:351\u2013356","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"198_CR23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018275","volume":"10","author":"JT Jacob","year":"2018","unstructured":"Jacob JT, Coulombe PA, Kwan R, Omary MB (2018) Types I and II keratin intermediate filaments. Cold Spring Harb Perspect Biol 10(4):a018275","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"198_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108782","volume":"34","author":"LK Jennings","year":"2021","unstructured":"Jennings LK, Dreifus JE, Reichhardt C, Storek KM, Secor PR, Wozniak DJ, Hisert KB, Parsek MR (2021) Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies. Cell Rep 34:108782","journal-title":"Cell Rep"},{"key":"198_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ijbiomac.2017.03.174","volume":"101","author":"Z Kalaycioglu","year":"2017","unstructured":"Kalaycioglu Z, Torlak E, Akin-Evingur G, Ozen I, Erim FB (2017) Antimicrobial and physical properties of chitosan films incorporated with turmeric extract. Int J Biol Macromol 101:882\u2013888","journal-title":"Int J Biol Macromol"},{"key":"198_CR26","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s10620-015-3546-7","volume":"60","author":"T Kelly","year":"2015","unstructured":"Kelly T, Buxbaum J (2015) Gastrointestinal manifestations of cystic fibrosis. Dig Dis Sci 60:1903\u20131913","journal-title":"Dig Dis Sci"},{"key":"198_CR27","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","volume":"57","author":"B Kocaadam","year":"2017","unstructured":"Kocaadam B, Sanlier N (2017) Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr 57:2889\u20132895","journal-title":"Crit Rev Food Sci Nutr"},{"key":"198_CR28","doi-asserted-by":"publisher","first-page":"24624","DOI":"10.1039\/D0RA04778C","volume":"10","author":"G Kuang","year":"2020","unstructured":"Kuang G, Zhang Q, He S, Liu Y (2020) Curcumin-loaded PEGylated mesoporous silica nanoparticles for effective photodynamic therapy. RSC Adv 10:24624\u201324630","journal-title":"RSC Adv"},{"key":"198_CR29","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.3762\/bjnano.10.220","volume":"10","author":"N Lababidi","year":"2019","unstructured":"Lababidi N, Sigal V, Koenneke A, Schwarzkopf K, Manz A, Schneider M (2019) Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration. Beilstein J Nanotechnol 10:2280\u20132293","journal-title":"Beilstein J Nanotechnol"},{"key":"198_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejpb.2020.10.010","volume":"157","author":"N Lababidi","year":"2020","unstructured":"Lababidi N, Montefusco-Pereira CV, De Souza C-W, Lehr CM, Schneider M (2020) Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles. Eur J Pharm Biopharm 157:200\u2013210","journal-title":"Eur J Pharm Biopharm"},{"key":"198_CR31","first-page":"2235","volume":"46","author":"V Lampe","year":"1913","unstructured":"Lampe V, Milobedeska J (1913) Studien \u00fcber curcumin. Eur J Pharm Biopharm 46:2235\u20132240","journal-title":"Eur J Pharm Biopharm"},{"key":"198_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2019.01.010","volume":"38","author":"H Li","year":"2020","unstructured":"Li H, Sureda A, Devkota HP, Pittala V, Barreca D, Silva AS, Tewari D, Xu S, Nabavi SM (2020) Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv 38:107343","journal-title":"Biotechnol Adv"},{"key":"198_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100557","volume":"296","author":"F Li","year":"2021","unstructured":"Li F, Egea PF, Vecchio AJ, Asial I, Gupta M, Paulino J, Bajaj R, Dickinson MS, Ferguson-Miller S, Monk BC, Stroud RM (2021) Highlighting membrane protein structure and function: a celebration of the protein data bank. J Biol Chem 296:100557","journal-title":"J Biol Chem"},{"key":"198_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.10.043","volume":"536","author":"J Lin","year":"2018","unstructured":"Lin J, Cai Q, Tang Y, Xu Y, Wang Q, Li T, Xu H, Wang S, Fan K, Liu Z, Jin Y, Lin D (2018) PEGylated lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect. Int J Pharm 536:272\u2013282","journal-title":"Int J Pharm"},{"key":"198_CR35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1124\/jpet.105.097667","volume":"317","author":"J Lipecka","year":"2006","unstructured":"Lipecka J, Norez C, Bensalem N, Baudouin-Legros M, Planelles G, Becq F, Edelman A, Davezac N (2006) Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network. J Pharmacol Exp Ther 317:500\u2013505","journal-title":"J Pharmacol Exp Ther"},{"key":"198_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","volume":"18","author":"GL Lukacs","year":"2012","unstructured":"Lukacs GL, Verkman AS (2012) CFTR: folding, misfolding and correcting the DeltaF508 conformational defect. Trends Mol Med 18:81\u201391","journal-title":"Trends Mol Med"},{"key":"198_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.bjp.0706185","volume":"145","author":"YA Mahmmoud","year":"2005","unstructured":"Mahmmoud YA (2005) Curcumin modulation of Na, K-ATPase: phosphoenzyme accumulation, decreased K+ occlusion, and inhibition of hydrolytic activity. Br J Pharmacol 145:236\u2013245","journal-title":"Br J Pharmacol"},{"key":"198_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ejmech.2014.06.069","volume":"83","author":"L Ma'mani","year":"2014","unstructured":"Ma\u2019mani L, Nikzad S, Kheiri-Manjili H, Al-Musawi S, Saeedi M, Askarlou S, Foroumadi A, Shafiee A (2014) Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Eur J Med Chem 83:646\u2013654","journal-title":"Eur J Med Chem"},{"key":"198_CR39","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.3390\/app11114915","volume":"11","author":"AM Matei","year":"2021","unstructured":"Matei AM, Caruntu C, Tampa M, Georgescu SR, Matei C, Constantin MM, Constantin TV, Calina D, Ciubotaru DA, Badarau IA, Scheau C, Caruntu A (2021) Applications of nanosized-lipid-based drug delivery systems in wound care. Appl Sci 11:4915","journal-title":"Appl Sci"},{"key":"198_CR40","first-page":"2163","volume":"43","author":"J Milobedeska","year":"1910","unstructured":"Milobedeska J, Kostanecki V, Lampe V (1910) Structure of curcumin. Eur J Pharm Biopharm 43:2163\u20132170","journal-title":"Eur J Pharm Biopharm"},{"key":"198_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/pharmaceutics6020333","volume":"6","author":"P Muralidharan","year":"2014","unstructured":"Muralidharan P, Mallory E, Malapit M, Hayes D, Mansour HM (2014) Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers. Pharmaceutics 6:333\u2013353","journal-title":"Pharmaceutics"},{"key":"198_CR42","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA (2017) The essential medicinal chemistry of curcumin: miniperspective. J Med Chem 60:1620\u20131637","journal-title":"J Med Chem"},{"key":"198_CR43","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","volume":"288","author":"A Oliver","year":"2000","unstructured":"Oliver A, Canton R, Campo P, Baquero F, Blazquez J (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251\u20131254","journal-title":"Science"},{"key":"198_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/2472630318824334","volume":"24","author":"V Ong","year":"2019","unstructured":"Ong V, Mei V, Cao L, Lee K, Chung EJ (2019) Nanomedicine for cystic fibrosis. SLAS Technol 24:169\u2013180","journal-title":"SLAS Technol"},{"key":"198_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejps.2011.03.003","volume":"43","author":"MK Pandey","year":"2011","unstructured":"Pandey MK, Kumar S, Thimmulappa RK, Parmar VS, Biswal S, Watterson AC (2011) Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. Eur J Pharm Sci 43:16\u201324","journal-title":"Eur J Pharm Sci"},{"key":"198_CR46","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.fct.2017.11.051","volume":"111","author":"I Pinzaru","year":"2018","unstructured":"Pinzaru I, Coricovac D, Dehelean C, Moaca EA, Mioc M, Baderca F, Sizemore I, Brittle S, Marti D, Calina CD, Tsatsakis AM, Soica C (2018) Stable PEG-coated silver nanoparticles - A comprehensive toxicological profile. Food Chem Toxicol 111:546\u2013556","journal-title":"Food Chem Toxicol"},{"key":"198_CR47","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","volume":"32","author":"S Prasad","year":"2014","unstructured":"Prasad S, Gupta SC, Tyagi AK, Aggarwal BB (2014) Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv 32:1053\u20131064","journal-title":"Biotechnol Adv"},{"key":"198_CR48","doi-asserted-by":"publisher","first-page":"1375892","DOI":"10.1155\/2022\/1375892","volume":"2022","author":"C Quispe","year":"2022","unstructured":"Quispe C, Herrera-bravo J, Javed Z, Khan K, Raza S, Gulsunoglu-Konuskan Z, Da\u015ftan SD, Sytar O, Martorell M, Sharifi-Rad J, Calina D (2022) Therapeutic applications of curcumin in diabetes: a review and perspective. Biomed Res Int 2022:1375892","journal-title":"Biomed Res Int"},{"key":"198_CR49","first-page":"11169","volume":"8","author":"M Rafeey","year":"2020","unstructured":"Rafeey M, Nikniaz Z, Farshiradvar F, Sameni Z, Faramarzi E (2020) Effects of curcumin supplementation on quality of life of cystic fibrosis patients. Int J Pediatr 8:11169\u201311176","journal-title":"Int J Pediatr"},{"key":"198_CR50","first-page":"51","volume":"62","author":"A Roointan","year":"2016","unstructured":"Roointan A, Sharifi-Rad M, Badrzadeh F, Sharifi-Rad J (2016) A comparison between PLGA-PEG and NIPAAm-MAA nanocarriers in curcumin delivery for hTERT silencing in lung cancer cell line. Cell Mol Biol 62:51\u201356","journal-title":"Cell Mol Biol"},{"key":"198_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prrv.2007.02.004","volume":"8","author":"BK Rubin","year":"2007","unstructured":"Rubin BK (2007) Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 8:4\u20137","journal-title":"Paediatr Respir Rev"},{"key":"198_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jbio.202000350","volume":"14","author":"K Rupel","year":"2021","unstructured":"Rupel K, Zupin L, Brich S, Mardirossian M, Ottaviani G, Gobbo M, Di Lenarda R, Pricl S, Crovella S, Zacchigna S, Biasotto M (2021) Antimicrobial activity of amphiphilic nanomicelles loaded with curcumin against Pseudomonas aeruginosa alone and activated by blue laser light. J Biophotonics 14:e202000350","journal-title":"J Biophotonics"},{"key":"198_CR53","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00018-016-2391-y","volume":"74","author":"V Saint-Criq","year":"2017","unstructured":"Saint-Criq V, Gray MA (2017) Role of CFTR in epithelial physiology. Cell Mol Life Sci 74:93\u2013115","journal-title":"Cell Mol Life Sci"},{"key":"198_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113191","volume":"213","author":"V Sala","year":"2021","unstructured":"Sala V, Cnudde SJ, Murabito A, Massarotti A, Hirsch E, Ghigo A (2021) Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives. Eur J Med Chem 213:113191","journal-title":"Eur J Med Chem"},{"key":"198_CR55","first-page":"35","volume":"9","author":"B Salehi","year":"2020","unstructured":"Salehi B, Calina D, Docea AO, Koirala N, Aryal S, Lombardo D, Pasqua L, Taheri Y, Castillo CMS, Martorell M, Martins N, Iriti M, Suleria HAR, Sharifi-Rad J (2020) Curcumin\u2019s nanomedicine formulations for therapeutic application in neurological diseases. J Clin Med 9:35","journal-title":"J Clin Med"},{"key":"198_CR56","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.2147\/IDR.S263387","volume":"13","author":"P Sharifian","year":"2020","unstructured":"Sharifian P, Yaslianifard S, Fallah P, Aynesazi S, Bakhtiyari M, Mohammadzadeh M (2020) Investigating the effect of nano-curcumin on the expression of biofilm regulatory genes of pseudomonas aeruginosa. Infect Drug Resist 13:2477\u20132484","journal-title":"Infect Drug Resist"},{"key":"198_CR57","doi-asserted-by":"publisher","first-page":"40629","DOI":"10.1074\/jbc.M407308200","volume":"279","author":"Y Song","year":"2004","unstructured":"Song Y, Sonawane ND, Salinas D, Qian L, Pedemonte N, Galietta LJ, Verkman AS (2004) Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem 279:40629\u201340633","journal-title":"J Biol Chem"},{"key":"198_CR58","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.lpm.2017.04.012","volume":"46","author":"AL Stephenson","year":"2017","unstructured":"Stephenson AL, Stanojevic S, Sykes J, Burgel PR (2017) The changing epidemiology and demography of cystic fibrosis. Presse Med 46:e87\u2013e95","journal-title":"Presse Med"},{"key":"198_CR59","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2217\/nnm.12.80","volume":"7","author":"M Sun","year":"2012","unstructured":"Sun M, Su X, Ding B, He X, Liu X, Yu A, Lou H, Zhai G (2012) Advances in nanotechnology-based delivery systems for curcumin. Nanomedicine 7:1085\u20131100","journal-title":"Nanomedicine"},{"key":"198_CR60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fphar.2020.578823","volume":"11","author":"Y Taheri","year":"2021","unstructured":"Taheri Y, Jokovic N, Vitorovic J, Grundmann O, Maroyi A, Calina D (2021) The burden of the serious and difficult-to-treat infections and a new antibiotic available: cefiderocol. Front Pharmacol 11:18","journal-title":"Front Pharmacol"},{"key":"198_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-021-05224-6","volume":"22","author":"S Talebi","year":"2021","unstructured":"Talebi S, Safarian M, Jaafari MR, Sayedi SJ, Abbasi Z, Ranjbar G, Kianifar HR (2021) The effects of nano-curcumin as a nutritional strategy on clinical and inflammatory factors in children with cystic fibrosis: the study protocol for a randomized controlled trial. Trials 22:1\u201311","journal-title":"Trials"},{"key":"198_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccm.2015.10.004","volume":"37","author":"JS Talwalkar","year":"2016","unstructured":"Talwalkar JS, Murray TS (2016) The approach to pseudomonas aeruginosa in cystic fibrosis. Clin Chest Med 37:69\u201381","journal-title":"Clin Chest Med"},{"key":"198_CR63","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3390\/jcm8071023","volume":"8","author":"LM Trandafir","year":"2019","unstructured":"Trandafir LM, Leon MM, Frasinariu O, Baciu G, Dodi G, Cojocaru E (2019) Current practices and potential nanotechnology perspectives for pain related to cystic fibrosis. J Clin Med 8:1023","journal-title":"J Clin Med"},{"key":"198_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/metabo9120290","volume":"9","author":"D Tsoukalas","year":"2019","unstructured":"Tsoukalas D, Sarandi E, Thanasoula M, Docea AO, Tsilimidos G, Calina D, Tsatsakis A (2019) Metabolic fingerprint of chronic obstructive lung diseases: a new diagnostic perspective. Metabolites 9:18","journal-title":"Metabolites"},{"key":"198_CR65","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fbioe.2019.00406","volume":"7","author":"C Velino","year":"2019","unstructured":"Velino C, Carella F, Adamiano A, Sanguinetti M, Vitali A, Catalucci D, Bugli F, Iafisco M (2019) Nanomedicine approaches for the pulmonary treatment of cystic fibrosis. Front Bioeng Biotechnol 7:406","journal-title":"Front Bioeng Biotechnol"},{"key":"198_CR66","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.ymthe.2019.07.002","volume":"27","author":"O Villamizar","year":"2019","unstructured":"Villamizar O, Waters SA, Scott T, Saayman S, Grepo N, Urak R, Davis A, Jaffe A, Morris KV (2019) Targeted activation of cystic fibrosis transmembrane conductance regulator. Mol Ther 27:1737\u20131748","journal-title":"Mol Ther"},{"key":"198_CR67","first-page":"312","volume":"3","author":"E Vogel","year":"1842","unstructured":"Vogel E (1842) Die Bibliothek Der Benediktinerabtei Sponheim. Serapeum 3:312\u2013328","journal-title":"Serapeum"},{"key":"198_CR68","unstructured":"Vogel HA, Pelletier J (1815)\nCurcumin\u2013biological and medicinal properties. J Pharma 2:50"},{"key":"198_CR69","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1021\/bi501318h","volume":"54","author":"G Wang","year":"2015","unstructured":"Wang G (2015) Interplay between inhibitory ferric and stimulatory curcumin regulates phosphorylation-dependent human cystic fibrosis transmembrane conductance regulator and DeltaF508 activity. Biochemistry 54:1558\u20131566","journal-title":"Biochemistry"},{"key":"198_CR70","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1074\/jbc.M609942200","volume":"282","author":"W Wang","year":"2007","unstructured":"Wang W, Bernard K, Li G, Kirk KL (2007) Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains. J Biol Chem 282:4533\u20134544","journal-title":"J Biol Chem"},{"key":"198_CR71","first-page":"1994","volume":"19","author":"MM Yallapu","year":"2013","unstructured":"Yallapu MM, Jaggi M, Chauhan SC (2013) Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des 19:1994\u20132010","journal-title":"Curr Pharm Des"},{"key":"198_CR72","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","volume":"17","author":"MM Yallapu","year":"2015","unstructured":"Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC (2015) Therapeutic applications of curcumin nanoformulations. AAPS J 17:1341\u20131356","journal-title":"AAPS J"},{"key":"198_CR73","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.2147\/IJN.S208332","volume":"14","author":"H Yavarpour-Bali","year":"2019","unstructured":"Yavarpour-Bali H, Ghasemi-Kasman M, Pirzadeh M (2019) Curcumin-loaded nanoparticles: a novel therapeutic strategy in treatment of central nervous system disorders. Int J Nanomedicine 14:4449\u20134460","journal-title":"Int J Nanomedicine"},{"key":"198_CR74","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1056\/NEJMcibr041584","volume":"351","author":"P Zeitlin","year":"2004","unstructured":"Zeitlin P (2004) Can curcumin cure cystic fibrosis? N Engl J Med 351:606\u2013608","journal-title":"N Engl J Med"}],"container-title":["Progress in Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40204-022-00198-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40204-022-00198-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40204-022-00198-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T02:26:30Z","timestamp":1751509590000},"score":1,"resource":{"primary":{"URL":"https:\/\/oiccpress.com\/pibm\/article\/view\/10374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s40204-022-00198-3","relation":{},"ISSN":["2194-0509","2194-0517"],"issn-type":[{"value":"2194-0509","type":"print"},{"value":"2194-0517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}